Cue Biopharma Inc (CUE)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Cue Biopharma Inc-Aktie (CUE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	601.66% 2.954	0.421	1.576	3.336	2.658
Operating Expenses	8.89% 11.59	12.72	11.21	12.15	13.04
Benefits Costs and Expenses	100.00% -	12.68	11.07	-	-
Costs And Expenses	8.59% 11.59	12.68	11.07	12.15	13.04
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Depreciation and Amortization	1.98% 0.099	0.101	0.098	0.101	0.099
Operating Income/Loss	29.79% -8.635	-12.30	-9.633	-8.815	-10.38
Net Interest Income/Expense	64.84% -0.045	-0.128	-0.153	-0.188	-0.215
Nonoperating Income/Loss	264.29% 0.153	0.042	0.137	0.155	0.212
Income/Loss From Continuing Operations Before Tax	124.10% 2.954	-12.26	-9.496	3.336	2.658
Income/Loss From Continuing Operations After Tax	30.80% -8.482	-12.26	-9.496	-8.66	-10.17
Net Income/Loss	30.80% -8.482	-12.26	-9.496	-8.66	-10.17
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	28.56% 95.46	74.25	6.0354	51.23	50.17
Diluted Average Shares	28.56% 95.46	74.25	6.0354	51.23	50.17
Basic Earnings Per Share	47.06% -0.09	-0.17	-0.10	-0.17	-0.20
Diluted Earnings Per Share	47.06% -0.09	-0.17	-0.10	-0.17	-0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$35.92

1.18%

INCY

$84.92

2.30%

SMMT

$26.29

1.50%

INSM

$127.27

0.41%

BNTX

$112.55

0.85%

ONC

$319.32

0.63%